Pharmacology · Nicotinic acid and derivatives
Nicotinic acid (niacin) !
Vitamin B3 used at high doses to lower triglycerides and LDL and raise HDL. Flushing, high glucose and liver effects limit it.
Updated 2026-11-01
Also called: niacin, vitamin B3
The figure shows nicotinic acid bound to human HCA2 (cryo-EM, receptor region after local refinement).
Mechanism of action
In adipose tissue, niacin acts on the Gi-coupled receptor HCA2 (GPR109A), lowering cAMP and the activity of hormone-sensitive lipase; fewer fatty acids reach the liver. In the liver it inhibits fatty acid synthesis and esterification, so less triglyceride is made, apo B is degraded and less VLDL (and later LDL) is released. It also raises HDL and increases lipoprotein lipase activity. Prostaglandins released through the same receptor in skin cause flushing.
- Activates HCA2 (Gi) on fat cells: less lipolysis
- Fewer fatty acids reach the liver
- Liver makes less triglyceride and VLDL
- Triglycerides and LDL fall; HDL rises
Pharmacokinetics
- Absorption
- Oral; immediate-release niacin is almost completely and rapidly absorbed.
- Metabolism
- Rapid metabolism in the liver.
- Elimination
- By the kidneys, as metabolites.
- Half-life
- Short for the immediate-release form (well under an hour), which is why extended-release forms exist.
Indications
- Dyslipidemia with high triglycerides or LDL when other drugs are not suitable Atherosclerosis and dyslipidaemia →
- Very high triglycerides with risk of pancreatitis, as an adjunct Familial hypertriglyceridaemia →
- Pellagra (niacin deficiency), at vitamin doses Pellagra (niacin deficiency) →
Adverse effects
Common
- Flushing, warmth and itching of the face and upper body
- Dyspepsia, nausea, diarrhea
- Rise in fasting glucose
- Rise in uric acid
Contraindications
- Active liver disease or unexplained persistent transaminase rises
- Active peptic ulcer disease
- Arterial bleeding
- Hypersensitivity to niacin
Key interactions
- Statins
- Add to the risk of myopathy and rhabdomyolysis.
- Bile acid sequestrants
- Bind niacin; 4 to 6 hours or more are left between them.
- Aspirin
- Reduces flushing; it may also lower the clearance of nicotinic acid (clinical relevance unclear).
- Insulin and other antidiabetic drugs
- Niacin raises glucose, so antidiabetic needs may increase.
- Antihypertensives and other vasoactive drugs
- Niacin can add to their effect and cause postural hypotension.
What is monitored
- Liver enzymes before and during treatment
- Fasting glucose, especially in diabetes
- Uric acid
- Lipid panel; phosphorus and platelets when relevant
Administration and safety
- The extended-release tablet is usually taken at bedtime after a low-fat snack and swallowed whole, never split, crushed or chewed.
- Immediate-release and extended-release products are not interchangeable at the same dose.
- Alcohol, hot drinks and spicy food around the dose worsen flushing.
- Niacin is also sold as a supplement: the prescribed product is checked, not a non-prescription substitute.
Nursing care
- Before: liver enzymes, glucose, uric acid, history of gout, ulcer or bleeding.
- Warn that flushing is expected and usually lessens after some weeks; teach the aspirin plan if prescribed.
- Ask about dizziness on standing, muscle pain, dark urine or jaundice.
- In diabetes, check glucose more often after starting.
Pregnancy and breastfeeding
Stopped when pregnancy is recognized if used for lipids; breastfeeding is not recommended during treatment.
Test yourself
Think of the answer, then tap the question to see it.
Through which receptor does niacin reduce lipolysis in fat tissue?
HCA2 (GPR109A), a Gi-coupled receptor that lowers cAMP and hormone-sensitive lipase activity.
Why is niacin used with caution in diabetes?
It causes insulin resistance and raises glucose; glucose is monitored more often.
What is the classic «3 D» deficiency disease treated with niacin at vitamin doses?
Pellagra: dermatitis, diarrhea and dementia.
Related drugs
Related conditions
← Back to the class: Nicotinic acid and derivatives
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: Niacin: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); DailyMed - NIACIN tablet, extended release (DailyMed (U.S. National Library of Medicine), 2026); Cryo-EM structure of niacin bound human hydroxy-carboxylic acid receptor 2 (Local refinement) (RCSB Protein Data Bank, 2023); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 37 (McGraw Hill, 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.